In Silico Modeling Demonstrates that User Variability During Tumor Measurement Can Affect In Vivo Therapeutic Efficacy Outcomes
User measurement bias during subcutaneous tumor measurement is a source of variation in preclinical in vivo studies. We investigated whether this user variability could impact efficacy study outcomes, in the form of the false negative result rate when comparing treated and control groups. Two tumor...
Main Authors: | Jake T Murkin, Hope E Amos, Daniel W Brough, Karl D Turley |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-11-01
|
Series: | Cancer Informatics |
Online Access: | https://doi.org/10.1177/11769351221139257 |
Similar Items
-
Trends in Subcutaneous Tumour Height and Impact on Measurement Accuracy
by: Daniel Brough, et al.
Published: (2023-04-01) -
In silico and in vivo demonstration of the regulatory mechanism of Qi-Ge decoction in treating NAFLD
by: Chong Peng, et al.
Published: (2023-12-01) -
In vivo detection of amyloid plaques by gadolinium-stained MRI can be used to demonstrate the efficacy of an anti-amyloid immunotherapy
by: Mathieu D. Santin, et al.
Published: (2016-03-01) -
Cannabis sativa demonstrates anti-hepatocellular carcinoma potentials in animal model: in silico and in vivo studies of the involvement of Akt
by: Dorcas I. Akinloye, et al.
Published: (2023-07-01) -
Creating user interfaces by demonstration /
by: 364872 Myers, Brad A.
Published: (1988)